Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure DK-2020-21/958 – Updated – measures in Denmark
|Country||Denmark , applies nationwide|
|Time period||Temporary, 20 May 2020 – 30 June 2021|
|Type||Legislations or other statutory regulations|
Income protection beyond short-time work
– Paid sick leave
|Author||Carsten Jørgensen (FAOS, University of Copenhagen), Anders Randrup (Oxford Research) and Eurofound|
|Measure added||10 July 2020 (updated 11 May 2021)|
In May, the Danish Parliament agreed on a solution in the sickness benefit system, so that people in the special risk group for COVID-19 and their relatives are guaranteed support if they stay home during the reopening of Denmark.
The Parliament has allocated a reserve of DKK 200 million to the scheme.
The scheme came into force in May 20, and will apply until September 1.
The scheme is based on the National Board of Health's list of diseases and conditions that may lead to an increased risk of an elongated or serious course of illness in the case of COVID-19 infection, and the National Board of Health's recommendations for relatives of persons in the risk group. It is the individual's doctor who must specifically assess whether the employee is in the risk group or is related to a person in the risk group.
Persons in the special risk group and relatives may, in agreement with the employer, stay away from work during the reopening of Denmark and receive wages during the absence period or sickness benefit if the employer does not pay wages. The premise is that there are no opportunities to work from home or be relocated so that you are not exposed to the risk of infection.
Private and public employers who pay salaries to employees at risk or relatives while at home are entitled to sickness benefit reimbursement from the first day of absence.
The following updates to this measure have been made after it came into effect.
|23 March 2021||
The measure is extended until 30 June 2021.
|22 December 2020||
The measure is extended until 31 March 2021.
|26 August 2020||
The Government and parties have agreed to extend the measure until 31 December 2020.
The COVID-19 risk group at the workplace
||Applies to all businesses||
The COVID-19 risk group
Social partners' role in designing the measure and form of involvement:
|Trade unions||Employers' organisations|
|Role||No involvement||No involvement|
|Form||Not applicable||Not applicable|
Social partners' role in the implementation, monitoring and assessment phase:
There were no particular reactions to the measure from the social partners.
Eurofound (2020), Support for people at higher risk of severe illness from COVID-19 virus, measure DK-2020-21/958 (measures in Denmark), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/DK-2020-21_958.html
30 January 2023
Governments across the EU continue to implement policies to support citizens and businesses in the face of rising food and energy prices caused by the COVID-19 crisis and intensified by the war in Ukraine. This article summarises the policy responses as reported in Eurofound's EU PolicyWatch database from January to September 2022.Article
12 September 2022
Although the worldwide pandemic situation had already disrupted supply chains and triggered increases in energy and food prices in 2021, the situation deteriorated in 2022 with the Russian invasion of Ukraine.Article
12 September 2022
This article summarises the first policy responses that governments across the EU have started to implement to support companies affected by the rising prices, and those with commercial ties to Ukraine, Russia or Belarus.Article
5 July 2022
This article summarises the first policy responses of EU Member States, including those of the social partners and other civil society actors, enabling refugees to exercise their rights under the Temporary Protection Directive.Article
Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.